Consolidated Statements of Cash Flows - USD ($)	12 Months Ended		17 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2025
OPERATING ACTIVITIES
Net loss	$ (6,869,000)	$ (7,732,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Share-based compensation expense	2,010,000	2,402,000
Depreciation	5,000	14,000
Amortization of operating lease right-of-use assets	98,000	153,000
Changes in operating assets and liabilities:
Accounts receivable	215,000	(227,000)
Inventory	64,000	(30,000)
Prepaid research and development	72,000	120,000
Prepaid expenses and other current assets	149,000	55,000
Deferred financing costs	0	544,000
Long-term prepaid contracts	257,000	310,000	$ (600,000)
Accounts payable	2,000	7,000
Operating lease liability	(95,000)	(152,000)
Accrued and other current liabilities	311,000	(254,000)
Deferred revenue	252,000	0
Net cash used in operating activities	(3,828,000)	(4,852,000)
FINANCING ACTIVITIES
Proceeds from issuance of common stock	2,700,000	6,482,000
Proceeds from exercise of warrants	0	430,000
Net cash provided by financing activities	2,700,000	6,912,000
Net (decrease) increase in cash and cash equivalents	(1,134,000)	2,054,000
Cash and cash equivalents at the beginning of the year	2,486,000	432,000
Cash and cash equivalents at the end of the year	1,352,000	2,486,000	$ 1,352,000
Effect of exchange rate changes on cash	(6,000)	(6,000)
SUPPLEMENTAL INFORMATION
Interest paid in cash	9,000	38,000
Supplemental disclosure of non-cash activities:
Right-of-use asset and lease liability (new lease)	0	398,000
Insurance premium financing	229,000	315,000
Related Party [Member]
FINANCING ACTIVITIES
Proceeds from convertible debt – related party	0	500,000
Payments on convertible debt – related party	0	(500,000)
Insurance Premium Financing Payable [Member]
Changes in operating assets and liabilities:
Insurance premium financing payable	$ (299,000)	$ (62,000)